Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Bridgeman VL"'
Autor:
Bridgeman, VL, Vermeulen, PB, Foo, S, Bilecz, A, Daley, F, Kostaras, E, Nathan, MR, Wan, E, Frentzas, S, Schweiger, T, Hegedus, B, Hoetzenecker, K, Renyi-Vamos, F, Kuczynski, EA, Vasudev, NS, Larkin, J, Gore, M, Dvorak, HF, Paku, S, Kerbel, RS, Dome, B, Reynolds, AR
Publikováno v:
The Journal of Pathology
Anti‐angiogenic therapies have shown limited efficacy in the clinical management of metastatic disease, including lung metastases. Moreover, the mechanisms via which tumours resist anti‐angiogenic therapies are poorly understood. Importantly, rat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8c406c28e5de15afb9f0c82b91706c95
https://pubmed.ncbi.nlm.nih.gov/27859259
https://pubmed.ncbi.nlm.nih.gov/27859259
Autor:
Rodrigues FS; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Karoutas A; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Ruhland S; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Rabas N; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Rizou T; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Di Blasio S; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Ferreira RMM; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Bridgeman VL; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Goldstone R; Bioinformatics & Biostatistics Unit, The Francis Crick Institute, London, UK., Sopena ML; Bioinformatics & Biostatistics Unit, The Francis Crick Institute, London, UK., Lee JH; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Ombrato L; Barts Cancer Institute, Queen Mary University of London, London, UK., Malanchi I; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK. Electronic address: ilaria.malanchi@crick.ac.uk.
Publikováno v:
Developmental cell [Dev Cell] 2024 Sep 23; Vol. 59 (18), pp. 2398-2413.e8. Date of Electronic Publication: 2024 Jun 11.
Autor:
Cuypers A; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium., Teuwen LA; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium; Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, 2610 Antwerp, Belgium; Center for Oncological Research, University of Antwerp, 2000 Antwerp, Belgium., Bridgeman VL; Tumour Host Interaction Laboratory, The Francis Crick Institute, London NW1 1AT, UK., de Rooij LPMH; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium., Eelen G; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium., Dewerchin M; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium., Cantelmo AR; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium., Kalucka J; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium., Bouché A; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium., Vinckier S; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium., Carton A; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium., Manderveld A; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium., Vermeulen PB; Translational Cancer Research Unit, GZA Hospitals Sint-Augustinus, 2610 Antwerp, Belgium; Center for Oncological Research, University of Antwerp, 2000 Antwerp, Belgium., Reynolds AR; Oncology R&D, AstraZeneca, Cambridge CB2 0AA, UK., Carmeliet P; Laboratory of Angiogenesis and Vascular Metabolism, Center for Cancer Biology (CCB), VIB, Department of Oncology, Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgium; Laboratory of Angiogenesis and Vascular Heterogeneity, Department of Biomedicine, Aarhus University, 8000 Aarhus, Denmark; Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi 127788, United Arab Emirates. Electronic address: peter.carmeliet@kuleuven.be.
Publikováno v:
STAR protocols [STAR Protoc] 2022 Dec 16; Vol. 3 (4), pp. 101691. Date of Electronic Publication: 2022 Sep 28.
Autor:
Cioce A; Department of Chemistry, Imperial College London, London, W12 0BZ, UK.; Chemical Glycobiology Laboratory, The Francis Crick Institute, London, NW1 1AT, UK., Calle B; Department of Chemistry, Imperial College London, London, W12 0BZ, UK.; Chemical Glycobiology Laboratory, The Francis Crick Institute, London, NW1 1AT, UK.; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, NW1 1AT, UK., Rizou T; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, NW1 1AT, UK., Lowery SC; Department of Chemistry, Yale University, New Haven, CT 06511, USA., Bridgeman VL; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, NW1 1AT, UK., Mahoney KE; Department of Chemistry, Yale University, New Haven, CT 06511, USA., Marchesi A; Department of Chemistry, Imperial College London, London, W12 0BZ, UK.; Chemical Glycobiology Laboratory, The Francis Crick Institute, London, NW1 1AT, UK., Bineva-Todd G; Chemical Glycobiology Laboratory, The Francis Crick Institute, London, NW1 1AT, UK., Flynn H; Proteomics Science Technology Platform, The Francis Crick Institute, London, NW1 1AT, UK., Li Z; Department of Chemistry, Imperial College London, London, W12 0BZ, UK.; Chemical Glycobiology Laboratory, The Francis Crick Institute, London, NW1 1AT, UK., Tastan OY; Chemical Glycobiology Laboratory, The Francis Crick Institute, London, NW1 1AT, UK., Roustan C; Structural Biology Science Technology Platform, The Francis Crick Institute, London, NW1 1AT, UK., Soro-Barrio P; Bioinformatics & Biostatistics Science Technology Platform, The Francis Crick Institute, London, NW1 1AT, UK., Rafiee MR; RNA Networks Laboratory, The Francis Crick Institute, London, NW1 1AT, UK., Garza-Garcia A; Mycobacterial Metabolism and Antibiotic Research Laboratory, The Francis Crick Institute, London, NW1 1AT, UK., Antonopoulos A; Department of Life Sciences, Imperial College London, London, SW7 2AZ, UK., Wood TM; Sarafan ChEM-H, Department of Chemistry and Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305, USA.; Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Keenan T; Department of Chemistry, University of York, York, YO10 5DD, UK., Both P; School of Chemistry & Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN, UK.; R&D Department, Axxence Slovakia s.r.o., 81107, Bratislava, Slovakia., Huang K; School of Chemistry & Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN, UK.; Department of Chemistry and Biochemistry, University of Maryland, College Park, MD 20742, USA., Parmeggian F; School of Chemistry & Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN, UK.; Department of Chemistry, Materials and Chemical Engineering 'G. Natta', Politecnico di Milano, 20131, Milano, Italy., Snijders AP; Proteomics Science Technology Platform, The Francis Crick Institute, London, NW1 1AT, UK., Skehel M; Proteomics Science Technology Platform, The Francis Crick Institute, London, NW1 1AT, UK., Kjær S; Structural Biology Science Technology Platform, The Francis Crick Institute, London, NW1 1AT, UK., Fascione MA; Department of Chemistry, University of York, York, YO10 5DD, UK., Bertozzi CR; Sarafan ChEM-H, Department of Chemistry and Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305, USA., Haslam SM; Department of Life Sciences, Imperial College London, London, SW7 2AZ, UK., Flitsch SL; School of Chemistry & Institute of Biotechnology, The University of Manchester, Manchester, M1 7DN, UK., Malaker SA; Department of Chemistry, Yale University, New Haven, CT 06511, USA., Malanchi I; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, NW1 1AT, UK., Schumann B; Department of Chemistry, Imperial College London, London, W12 0BZ, UK. b.schumann@imperial.ac.uk.; Chemical Glycobiology Laboratory, The Francis Crick Institute, London, NW1 1AT, UK. b.schumann@imperial.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2022 Oct 25; Vol. 13 (1), pp. 6237. Date of Electronic Publication: 2022 Oct 25.
Autor:
Nolan E; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK., Bridgeman VL; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK., Ombrato L; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK.; Barts Cancer Institute, Queen Mary University of London, London, UK., Karoutas A; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK., Rabas N; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK., Sewnath CAN; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK., Vasquez M; Cancer Immunology Unit, UCL Cancer Institute, University College London, London, UK., Rodrigues FS; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK., Horswell S; Bioinformatics & Biostatistics Unit, The Francis Crick Institute, London, UK., Faull P; Proteomics Unit, The Francis Crick Institute, London, UK.; Center for Biomedical Research Support Biological Mass Spectrometry Facility, The University of Texas at Austin, Austin, TX, USA., Carter R; Preclinical Radiotherapy TTP, CRUK-City of London Centre, UCL Cancer Institute, University College London, London, UK., Malanchi I; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK. Ilaria.Malanchi@crick.ac.uk.
Publikováno v:
Nature cancer [Nat Cancer] 2022 Apr; Vol. 3 (4), pp. 519.
Autor:
Nolan E; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK., Bridgeman VL; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK., Ombrato L; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK.; Barts Cancer Institute, Queen Mary University of London, London, UK., Karoutas A; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK., Rabas N; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK., Sewnath CAN; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK., Vasquez M; Cancer Immunology Unit, UCL Cancer Institute, University College London, London, UK., Rodrigues FS; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK., Horswell S; Bioinformatics & Biostatistics Unit, The Francis Crick Institute, London, UK., Faull P; Proteomics Unit, The Francis Crick Institute, London, UK.; Center for Biomedical Research Support Biological Mass Spectrometry Facility, The University of Texas at Austin, Austin, TX, USA., Carter R; Preclinical Radiotherapy TTP, CRUK-City of London Centre, UCL Cancer Institute, University College London, London, UK., Malanchi I; Tumour Host Interaction laboratory, The Francis Crick Institute, London, UK. Ilaria.Malanchi@crick.ac.uk.
Publikováno v:
Nature cancer [Nat Cancer] 2022 Feb; Vol. 3 (2), pp. 173-187. Date of Electronic Publication: 2022 Feb 24.
Autor:
Ombrato L; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK. l.ombrato@qmul.ac.uk.; Barts Cancer Institute, Queen Mary University of London, London, UK. l.ombrato@qmul.ac.uk., Nolan E; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Passaro D; Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, London, UK.; Leukemia and Niche Dynamics Laboratory, Cochin Institute, Paris, France., Kurelac I; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK.; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy.; Centro di Ricerca Biomedica Applicata (CRBA), Università di Bologna, Bologna, Italy., Bridgeman VL; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Waclawiczek A; Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, London, UK., Duarte D; Department of Life Sciences, Imperial College London, London, UK.; Bone Marrow Dynamics Laboratory, The Francis Crick Institute, London, UK., Lo Celso C; Department of Life Sciences, Imperial College London, London, UK.; Bone Marrow Dynamics Laboratory, The Francis Crick Institute, London, UK., Bonnet D; Haematopoietic Stem Cell Laboratory, The Francis Crick Institute, London, UK., Malanchi I; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK. ilaria.malanchi@crick.ac.uk.
Publikováno v:
Nature protocols [Nat Protoc] 2021 Feb; Vol. 16 (2), pp. 872-892. Date of Electronic Publication: 2020 Dec 11.
Autor:
Rodriguez-Hernandez I; Barts Cancer Institute, Queen Mary University of London, John Vane Science Building, Charterhouse Square, London, EC1M 6BQ, UK.; Randall Division of Cell and Molecular Biophysics, New Hunt's House, Guy's Campus, King's College London, London, SE1 1UL, UK., Maiques O; Barts Cancer Institute, Queen Mary University of London, John Vane Science Building, Charterhouse Square, London, EC1M 6BQ, UK.; Randall Division of Cell and Molecular Biophysics, New Hunt's House, Guy's Campus, King's College London, London, SE1 1UL, UK., Kohlhammer L; Barts Cancer Institute, Queen Mary University of London, John Vane Science Building, Charterhouse Square, London, EC1M 6BQ, UK.; Randall Division of Cell and Molecular Biophysics, New Hunt's House, Guy's Campus, King's College London, London, SE1 1UL, UK., Cantelli G; Randall Division of Cell and Molecular Biophysics, New Hunt's House, Guy's Campus, King's College London, London, SE1 1UL, UK.; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA., Perdrix-Rosell A; Barts Cancer Institute, Queen Mary University of London, John Vane Science Building, Charterhouse Square, London, EC1M 6BQ, UK.; Randall Division of Cell and Molecular Biophysics, New Hunt's House, Guy's Campus, King's College London, London, SE1 1UL, UK.; Tumour Host Interaction Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Monger J; Barts Cancer Institute, Queen Mary University of London, John Vane Science Building, Charterhouse Square, London, EC1M 6BQ, UK., Fanshawe B; Randall Division of Cell and Molecular Biophysics, New Hunt's House, Guy's Campus, King's College London, London, SE1 1UL, UK.; Department of Imaging Chemistry and Biology, School of Biomedical Engineering and Imaging Sciences, Kings' College London, London, SE1 7EH, UK., Bridgeman VL; Tumour Host Interaction Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Karagiannis SN; St John's Institute of Dermatology, School of Basic & Medical Biosciences, King's College London and NIHR Biomedical Research Centre at Guy's and St Thomas' Hospitals and King's College London, London, SE1 9RT, UK., Penin RM; Department of Pathology, Hospital Universitari de Bellvitge, IDIBELL, l'Hospitalet de Llobregat, 08908, Barcelona, Spain., Marcolval J; Department of Dermatology, Hospital Universitari de Bellvitge, IDIBELL, l'Hospitalet de Llobregat, 08908, Barcelona, Spain., Marti RM; Department of Dermatology, Hospital Universitari Arnau de Vilanova, University of Lleida, IRB LleidaI, CIBERONC, 25198, Lleida, Spain., Matias-Guiu X; Department of Pathology and Molecular Genetics, Hospital Universitari Arnau de Vilanova, University of Lleida, IRB Lleida, CIBERONC, 25198, Lleida, Spain., Fruhwirth GO; Department of Imaging Chemistry and Biology, School of Biomedical Engineering and Imaging Sciences, Kings' College London, London, SE1 7EH, UK., Orgaz JL; Barts Cancer Institute, Queen Mary University of London, John Vane Science Building, Charterhouse Square, London, EC1M 6BQ, UK.; Randall Division of Cell and Molecular Biophysics, New Hunt's House, Guy's Campus, King's College London, London, SE1 1UL, UK.; Instituto de Investigaciones Biomedicas 'Alberto Sols', CSIC-UAM, 28029, Madrid, Spain., Malanchi I; Tumour Host Interaction Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK., Sanz-Moreno V; Barts Cancer Institute, Queen Mary University of London, John Vane Science Building, Charterhouse Square, London, EC1M 6BQ, UK. v.sanz-moreno@qmul.ac.uk.; Randall Division of Cell and Molecular Biophysics, New Hunt's House, Guy's Campus, King's College London, London, SE1 1UL, UK. v.sanz-moreno@qmul.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2020 Oct 20; Vol. 11 (1), pp. 5315. Date of Electronic Publication: 2020 Oct 20.
Autor:
Wculek SK; Tumour Host Interaction Laboratory, The Francis Crick Institute, 1 Midland Road, NW1 1AT London, UK., Bridgeman VL; Tumour Host Interaction Laboratory, The Francis Crick Institute, 1 Midland Road, NW1 1AT London, UK., Peakman F; Tumour Host Interaction Laboratory, The Francis Crick Institute, 1 Midland Road, NW1 1AT London, UK., Malanchi I; Tumour Host Interaction Laboratory, The Francis Crick Institute, 1 Midland Road, NW1 1AT London, UK. Electronic address: ilaria.malanchi@crick.ac.uk.
Publikováno v:
IScience [iScience] 2020 Jul 24; Vol. 23 (7), pp. 101277. Date of Electronic Publication: 2020 Jun 17.
Autor:
Ombrato L; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Nolan E; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Kurelac I; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK.; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy., Mavousian A; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., Bridgeman VL; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Heinze I; Proteomics of Aging, Leibniz Institute on Aging, Fritz Lipmann Institute (FLI), Jena, Germany., Chakravarty P; Bioinformatics and Biostatistics Unit, The Francis Crick Institute, London, UK., Horswell S; Bioinformatics and Biostatistics Unit, The Francis Crick Institute, London, UK., Gonzalez-Gualda E; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Matacchione G; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK., Weston A; Electron Microscopy Unit, The Francis Crick Institute, London, UK., Kirkpatrick J; Proteomics of Aging, Leibniz Institute on Aging, Fritz Lipmann Institute (FLI), Jena, Germany., Husain E; Department of Pathology, Aberdeen Royal Infirmary, Aberdeen, UK., Speirs V; Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK., Collinson L; Electron Microscopy Unit, The Francis Crick Institute, London, UK., Ori A; Proteomics of Aging, Leibniz Institute on Aging, Fritz Lipmann Institute (FLI), Jena, Germany., Lee JH; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. jhl62@cam.ac.uk.; Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK. jhl62@cam.ac.uk., Malanchi I; Tumour-Host Interaction Laboratory, The Francis Crick Institute, London, UK. Ilaria.Malanchi@crick.ac.uk.
Publikováno v:
Nature [Nature] 2019 Nov; Vol. 575 (7784), pp. E8.